MedTrace Logo

Randomized Controlled Trial for Exparel Hip Fracture

NCT03289858 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2021-03-18

Study results available
· View outcomes & findings →

Summary

This is a prospective, randomized study looking at the effect that a long-acting local anesthetic has on pain control in patients having surgery for hip fractures. The investigators are conducting the study to see if that reduces the amount of pain medicine needed after surgery, and if it reduces other medical complications after surgery.

Conditions

  • Hip Fractures

Interventions

DRUG

Exparel

Subcutaneous injection at conclusion of surgical fixation of hip fracture

DRUG

Sodium Chloride

Saline Injection

Sponsors & Collaborators

  • Orthopaedic Trauma Association

    collaborator OTHER

  • University of Kentucky

    collaborator OTHER

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Eric Swart, MD · UMass Memorial Health

  • Paul Matuszewski, MD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-01-01
Completion
2019-01-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03289858 on ClinicalTrials.gov